Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Adler

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Diabetes Care|February 28, 2014
Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.KAmanda Adler, Anna Casula, Retha Steenkamp, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|November 6, 2023
A Randomized Controlled Trial of Animal-assisted Activities for Pediatric Oncology Patients: Psychosocial and Microbial OutcomesJessica Chubak, Amanda Adler, Jennifer F Bobb, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Teplizumab approval for type 1 diabetes in the USADavid Beran, Carol Abidha, Amanda Adler, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2017
Rule-Out Outbreak: 24-Hour Metagenomic Next-Generation Sequencing for Characterizing Respiratory Virus Source for Infection PreventionAlexander L Greninger, Alpana Waghmare, Amanda Adler, et al.
Ebiomedicine|May 19, 2026
Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trialRui Gao, Ioannis Spiliotis, Haiqiang Dou, et al.
Diabetes Care|April 13, 2026
Hepatic Events Prevention by Antihyperglycemic Therapies and Intervention Comparisons in Type 2 Diabetes: The HEPATIC-T2DM Network Meta-analysisPedro Robson Costa Passos, Rodrigo Motta, Valbert Oliveira Costa Filho, et al.
Plos Medicine|April 7, 2025
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse eventsHeather Wightman, Elaine Butterly, Lili Wei, et al.
BMJ Public Health|February 28, 2025
Relationship of cardiorenal risk factors with albuminuria based on age, smoking, glycaemic status and BMI: a retrospective cohort study of the UK Biobank dataDebasish Kar, Aya El-Wazir, Mintu Nath, et al.
JAMA Network Open|June 11, 2025
Scenario Projections of Respiratory Syncytial Virus Hospitalizations Averted Due to New ImmunizationsChelsea L Hansen, Lawrence Lee, Samantha J Bents, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Diabetes Care|February 28, 2014
Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.KAmanda Adler, Anna Casula, Retha Steenkamp, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|November 6, 2023
A Randomized Controlled Trial of Animal-assisted Activities for Pediatric Oncology Patients: Psychosocial and Microbial OutcomesJessica Chubak, Amanda Adler, Jennifer F Bobb, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Teplizumab approval for type 1 diabetes in the USADavid Beran, Carol Abidha, Amanda Adler, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2017
Rule-Out Outbreak: 24-Hour Metagenomic Next-Generation Sequencing for Characterizing Respiratory Virus Source for Infection PreventionAlexander L Greninger, Alpana Waghmare, Amanda Adler, et al.
Ebiomedicine|May 19, 2026
Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trialRui Gao, Ioannis Spiliotis, Haiqiang Dou, et al.
Diabetes Care|April 13, 2026
Hepatic Events Prevention by Antihyperglycemic Therapies and Intervention Comparisons in Type 2 Diabetes: The HEPATIC-T2DM Network Meta-analysisPedro Robson Costa Passos, Rodrigo Motta, Valbert Oliveira Costa Filho, et al.
Plos Medicine|April 7, 2025
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse eventsHeather Wightman, Elaine Butterly, Lili Wei, et al.
BMJ Public Health|February 28, 2025
Relationship of cardiorenal risk factors with albuminuria based on age, smoking, glycaemic status and BMI: a retrospective cohort study of the UK Biobank dataDebasish Kar, Aya El-Wazir, Mintu Nath, et al.
JAMA Network Open|June 11, 2025
Scenario Projections of Respiratory Syncytial Virus Hospitalizations Averted Due to New ImmunizationsChelsea L Hansen, Lawrence Lee, Samantha J Bents, et al.
Pageof 8